(Немає відомостей про примірники) Шифр: AM1/2007/99/Suppl.6 Журнал 2007р. Vol. 99 Suppl.6 McKenney, J. Introduction / J. McKenney. - P.1C-2C Safety considerations with fibrate therapy. - P.3C-18C : il Brown, W. V. Expert commentary: the safety of fibrates in lipid-lowering therapy / W.V. Brown. - P.19C-21C Guyton, J. R. Safety considerations with Niacin therapy / J.R. Guyton, H.E. Bays. - P.22C-31C : il Brown, B. G. Expert commentary: Niacin safety / B.G. Brown. - P.32C-34C Bays, H. E. Safety considerations with Omega-3 fatty acid therapy. / H.E. Bays. - P.35C-43C : il Harris, W. S. Expert opinion: Omega-3 fatty acids and bleeding-cause for concern? / W.S. Harris. - P.44C-46C : il Safety considerations with gastrointestinally active lipid-lowering drugs. - P.47C-55C : il Toth, P. P. Expert commentary: gastrointestinally active lipid-lowering drug safety. / P.P. Toth. - P.56C-58C Немає відомостей про примірники |
(Немає відомостей про примірники) Шифр: AM1/2007/100/11A Журнал 2007р. Vol. 100 N 11A Davidson, M. H. Introduction. / M.H. Davidson, P.P. Toth. - P.1N-2N : il Ansell, B. J. Targeting the anti-inflammatory effects of high-density lipoprotein. / B.J. Ansell. - P.3N-9N : il Orloff, D. G. Regulatory considerations in the development of high-density lipoprotein therapies. / D.G. Orloff. - P.10N-14N Rader, D. J. Liver X receptor and farnesoid X receptor as therapeutic targets. / D.J. Rader. - P.15N-19N : цв.ил Sprecher, D. L. Lipids, lipoproteins, and peroxisome proliferator activated reseptor-б. / D.L. Sprecher. - P.20N-24N. : il Schaefer, E. J. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. / E.J. Schaefer, B.F. Asztalos. - P.25N-31N : il Davidson, M. H. High-density lipoprotein matabolism: potential therapeutic targets. / M.H. Davidson, P.P. Toth. - P.32N-40N. : il Fruchart, J. -Ch. Novel Peroxisome proliferator activated receptor-a agonist. / J.-Ch. Fruchart. - P.41N-46N : цв.ил Kastelein, J. J.P. Refocusing on use of cholesteryl ester transfer protein inhibitors. / J.J.P. Kastelein. - P.47N-52N : цв.ил Kamanna, V. S. : Nicotinic acid (Niacin) Receptor agonists: will they be useful therapeutic agents? / V.S. Kamanna, M.L. Kashyap. - P.53N-61N : il Shah, P. K. High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein. / P.K. Shah. - P.62N-67N : цв.ил Немає відомостей про примірники |
(Немає відомостей про примірники) Шифр: AM1/2007/100/11A Журнал 2007р. Vol. 100 N 11A Davidson, M. H. Introduction. / M.H. Davidson, P.P. Toth. - P.1N-2N : il Ansell, B. J. Targeting the anti-inflammatory effects of high-density lipoprotein. / B.J. Ansell. - P.3N-9N : il Orloff, D. G. Regulatory considerations in the development of high-density lipoprotein therapies. / D.G. Orloff. - P.10N-14N Rader, D. J. Liver X receptor and farnesoid X receptor as therapeutic targets. / D.J. Rader. - P.15N-19N : цв.ил Sprecher, D. L. Lipids, lipoproteins, and peroxisonne proliferator activated reseptor-б. / D.L. Sprecher. - P.20N-24N. : il Schaefer, E. J. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. / E.J. Schaefer, B.F. Asztalos. - P.25N-31N : il Davidson, M. H. High-density lipoprotein matabolism: potential therapeutic targets. / M.H. Davidson, P.P. Toth. - P.32N-40N. : il Fruchart, J. -Ch. Novel Peroxisome proliferator activated receptor-a agonist. / J.-Ch. Fruchart. - P.41N-46N : цв.ил Kastelein, J. J.P. Refocusing on use of cholesteryl ester transfer protein inhibitors. / J.J.P. Kastelein. - P.47N-52N : цв.ил Kamanna, V. S. : Nicotinic acid (Niacin) Receptor agonists: will they be useful therapeutic agents? / V.S. Kamanna, M.L. Kashyap. - P.53N-61N : il Shah, P. K. High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein. / P.K. Shah. - P.62N-67N : цв.ил Немає відомостей про примірники |
Davidson, M. H. Introduction. [Text] / M.H. Davidson, P.P. Toth // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.100, N11A. - P1N-2N : il . - ISSN 0002-9149 Дод.точки доступу: Toth, P.P. Экз-ры: |
Davidson, M. H. High-density lipoprotein matabolism: potential therapeutic targets. [Text] / M.H. Davidson, P.P. Toth // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.100, N11A. - P32N-40N. : il. - Ref. : p. 39N-40N. . - ISSN 0002-9149 Рубрики: ЛИПОПРОТЕИНЫ ВЫСОКОЙ ПЛОТНОСТИ--LIPOPROTEINS, HDL Дод.точки доступу: Toth, P.P. Экз-ры: |
Toth, P. P. Expert commentary: gastrointestinally active lipid-lowering drug safety. [Text] / P.P. Toth // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.99, NSuppl.6. - 56C-58C. - Ref. : p. 58C . - ISSN 0002-9149 Рубрики: АТЕРОСКЛЕРОЗ--ATHEROSCLEROSIS Кл.слова (ненормовані): ЭЗЕТИМИБ Экз-ры: |